Rachel Haring

Biochemistry, Genetics and Molecular Biology · Life Sciences

18h-index1.3kcitations52works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Receptor Mechanisms and Signaling(35), Neuroscience and Neuropharmacology Research(22), Alzheimer's disease research and treatments(10), Protein Kinase Regulation and GTPase Signaling(8), Nicotinic Acetylcholine Receptors Study(8)

Publications52 total

Beta-amyloids, tau hyperphosphorylation and cognition are beneficially affected by M1 muscarinic agonists
2004
Ligand-selective signaling and high-content screening for GPCR drugs
Drug Discovery Today·2003· 18 cited
M<sub>1</sub> Muscarinic Agonists Can Modulate Some of the Hallmarks in Alzheimer's Disease: Implications in Future Therapy
Journal of Molecular Neuroscience·2003· 147 cited
Bioactive lipids and their receptors.
PubMed·2002· 8 cited
Impact of muscarinic agonists for successful therapy of Alzheimer’s disease
Journal of neural transmission. Supplementum·2002· 18 cited
M1 Muscarinic Agonists as a Therapeutic Strategy in Alzheimer’s Disease
Advances in behavioral biology·2002· 1 cited
M1 Muscarinic Agonists as Potential Disease‐Modifying Agents in Alzheimer's Disease: Rationale and Perspectives
Annals of the New York Academy of Sciences·2000· 61 cited
M1 muscarinic agonists protect PC12M1 cells from growth factor deprivation and β-amyloids-induced apoptosis
Neurobiology of Aging·2000· 4 cited
Effect of muscarinic stimulation on β-amyloid precursor protein processing in rat brain and primary cultures
Life Sciences·1999
Mitogen‐Activated Protein Kinase‐Dependent and Protein Kinase C‐Dependent Pathways Link the m1 Muscarinic Receptor to β‐Amyloid Precursor Protein Secretion
Journal of Neurochemistry·1998· 122 cited
Novel m1 muscarinic agonists in treatment and delaying the progression of Alzheimer's disease: An unifying hypothesis
Journal of Physiology-Paris·1998· 14 cited
Muscarinic Modulation of β-Amyloid Precursor Protein (βApp) Processing in Vitro and in Vivo
Advances in behavioral biology·1998
THE MOLECULAR BASIS UNDERLYING THE DISCRETE ACTIVATION OF SIGNAL TRANSDUCTION PATHWAYS BY SELECTIVE MUSCARINIC AGONISTS Relevance to Treatment of Alzheimer's Disease
1998· 1 cited
The Molecular Basis Underlying the Discrete Activation of Signal Transduction Pathways by Selective Muscarinic Agonists
Advances in behavioral biology·1998
Ml Muscarinic Agonists: From Treatment Toward Delaying Progression of Alzheimer’s Disease
Advances in behavioral biology·1998
Selective neurotoxicity induced by the ionophore lasalocid in rat dissociated cerebral cultures, involvement of the NMDA receptor/channel.
PubMed·1997· 10 cited
An M1 selective agonist AF102b, as a potential drug in treatment of Alzheimer's disease: Biochemical and pharmacological properties
Life Sciences·1997
Nerve Cell Death Induced by Ca2+ Ionophores in Dissociated Hippocampal Cultures
Advances in experimental medicine and biology·1997· 3 cited
Novel M1 Agonists: From Symptomatic Treatment Towards Delaying the Progression of Alzheimer’s Disease
Birkhäuser Boston eBooks·1997
Muscarinic control of amyloid precursor protein secretion in rat cerebral cortex and cerebellum
Brain Research·1996· 40 cited
page 1 of 3Next →

Frequent Co-authors

Abraham Fisher(27), Zipora Pittel(25), Eliahu Heldman(24), David Gurwitz(18), Rachel Brandeis(16), Daniele Marciano(13), Yoel Kloog(13), Yishai Karton(12), Haim Meshulam(12), Mordechai Sokolovsky(7), N. Eshhar(5), Nira Bar-Ner(4), Itzhak Marcovitch(4), Jacob Barg(4), Dov Barak(4), Niva Natan(3), Hagar Sonego(3), Nomi Eshhar(3), Ishai Karton(3), Michal Sapir(3)